BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30402230)

  • 21. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
    Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
    Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
    Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.
    Stulp RP; Herkert JC; Karrenbeld A; Mol B; Vos YJ; Sijmons RH
    Hered Cancer Clin Pract; 2008 Feb; 6(1):15-21. PubMed ID: 19706203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Family Affected by Lynch Syndrome Caused by MSH6 Germline Mutation].
    Chika N; Kumamoto K; Suzuki O; Fukuchi M; Matsuzawa T; Kumagai Y; Ishibashi K; Eguchi H; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2211-4. PubMed ID: 26805314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.
    Sorscher S
    Oncologist; 2018 Nov; 23(11):1266-1268. PubMed ID: 29866945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome.
    Rashid MU; Naeemi H; Muhammad N; Loya A; Yusuf MA; Lubiński J; Jakubowska A; Hamann U
    Hered Cancer Clin Pract; 2016; 14():14. PubMed ID: 27413415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome.
    Mork ME; Rodriguez A; Taggart MW; Rodriguez-Bigas MA; Lynch PM; Bannon SA; You YN; Vilar E
    Fam Cancer; 2017 Jul; 16(3):357-361. PubMed ID: 28004223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations.
    Buecher B; De Pauw A; Bazire L; Houdayer C; Fievet A; Moncoutier V; Farkhondeh F; Melaabi S; Lyonnet DS; Golmard L
    Fam Cancer; 2018 Apr; 17(2):281-285. PubMed ID: 28819700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma.
    Kientz C; Joly MO; Faivre L; Clemenson A; Dalac S; Lepage C; Chapusot C; Jacquot C; Schiappa R; Lebrun M
    Hered Cancer Clin Pract; 2017; 15():6. PubMed ID: 28507641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.
    Ichikawa Y; Lemon SJ; Wang S; Franklin B; Watson P; Knezetic JA; Bewtra C; Lynch HT
    Cancer Genet Cytogenet; 1999 Jul; 112(1):2-8. PubMed ID: 10432927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study.
    Sun S; Liu Y; Eisfeld AK; Zhen F; Jin S; Gao W; Yu T; Chen L; Wang W; Chen W; Yuan M; Chen R; He K; Guo R
    Front Oncol; 2019; 9():550. PubMed ID: 31297337
    [No Abstract]   [Full Text] [Related]  

  • 32. Lynch Syndrome-Associated Endometrial Cancer With Combined EPCAM-MSH2 Deletion: A Case Report.
    Huang R; Deng X; Zhang Z; Wen Q; Li D
    Front Oncol; 2022; 12():856452. PubMed ID: 35311082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report.
    Ueda M; Watanabe T; Momma T; Kanke Y; Kato A; Okabe C; Sato T; Kamo N; Endo Y; Furukawa S; Soeda S; Fujimori K
    Mol Clin Oncol; 2024 Jul; 21(1):46. PubMed ID: 38826696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
    Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results.
    Olkinuora A; Gylling A; Almusa H; Eldfors S; Lepistö A; Mecklin JP; Nieminen TT; Peltomäki P
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
    Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
    Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous gynecologic malignancy and preliminary results of Lynch syndrome.
    Kim MK; Song SY; Do IG; Kim SH; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    J Gynecol Oncol; 2011 Dec; 22(4):233-8. PubMed ID: 22247799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.